Mechanisms include altered gut motility, changes in intestinal fluid secretion, and microbiome shifts
Tirzepatide (MOUNJARO) is a once-weekly subcutaneous injectable agent first authorized for T2DM and later extended to the management of obesity or overweight with at least one weight-related comorbidity, thereby aligning its therapeutic scope with subcutaneous liraglutide and semaglutide [34,35,36]
In addition, according to the Xie and colleagues, a theoretical risk of thyroid C-cell tumors exists, based on rodent studies
Key Benefits Gently cleanses dirt, oil, and impurities Helps improve the appearance of dull-looking skin Promotes a brighter and more radiant complexion Leaves skin feeling soft, smooth, and refreshed Supports a more even-looking skin tone Creates a rich and luxurious cleansing lather Suitable for daily face and body cleansing Suitable for most skin types How to Use Step 1: Wet your skin with water
While not a single abnormality was flagged in common by the two tests, perhaps if they are run together we can look for more subtle agreement between them